Login to Your Account



Pharma: Clinic Roundup


Wednesday, May 2, 2012
• Sanofi SA, of Paris, said vaccine division Sanofi Pasteur reported Phase III data from a pediatric study of quadrivalent influenza vaccine (QIV) in children 6 months through 8 years of age, with results supporting results in prior studies in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription